SAN DIEGO, Aug. 29, 2017 /PRNewswire/ -- MyDx, Inc. (OTCQB: MYDX), a rapidly growing science and
technology company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, announced
that it was recently featured by Canadian Tier 1 Media Outlets including Business News Network
(BNN), Toronto Life Magazine, and Global News.
CEO Daniel Yazbeck will also be speaking on a panel at MJAC2017 InvestorsHub International Cannabis Conference entitled "Investing in
the Picks and Shovels of the Industry" at 12:00 p.m. Pacific Time on Saturday September 2 nd at the JW Marriott Los Angeles.
About MyDx, Inc.
MyDx, Inc. (OTCQB: MYDX) is a chemical detection and sensor technology company based in San
Diego, California whose mission is to help people Trust & Verify® what they put into their minds and
bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical
analysis and fits in the palm of the user's hand. The multi-use MyDx analyzer leverages over a decade of established chemical
detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio
of patents covering its technology. The MyDx AquaDx®, OrganaDx(TM) and CannaDx(TM)
sensors are now commercialized, and the AeroDx® application is next in line. All sensors will be compatible with
a MyDx App that empowers consumers to live a healthier life by revealing the chemical composition of what they eat, drink
and inhale. For more information, please visit www.cdxlife.com.
Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act
of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain
forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other
statements relating to future operations and results. Any statements in this press release that are not statements of historical
fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate,"
"estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking
statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks
and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional
financing requirements, development of new products, our ability to complete our product testing and launch our product
commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis,
the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties
detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov.
Investor Contact:
MyDx Shareholder Communications
800.814.4550 ext. 4
ir@cdxlife.com
Photo - http://mma.prnewswire.com/media/549799/MyDx_Inc_CEO_Daniel_Yazbeck.jpg
SOURCE MyDx, Inc.